About Nasopharyngeal Cancer
Nasopharyngeal cancer is a disease in which malignant (cancer) cells form in the tissues of the nasopharynx. The nasopharynx is the upper part of the pharynx (throat) behind the nose. The nasopharynx is located at the base of the skull, above the roof of the mouth. It is the opening of the nostrils. The increasing geriatric population, rise in consumption of tobacco, increasing health awareness, changing lifestyle, are key driving factors for the nasopharyngeal cancer treatment market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Nasopharyngeal Cancer market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Sanofi (France), F. Hoffmann-La Roche (Switzerland), Merck & Co. (United States), Cyclacel Pharmaceuticals (United States), Celgene (United States), BioDiem (Canada), Biocon Limited (India), Bristol Myers Squibb (United States) and GlaxoSmithKline Plc (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Teva Pharmaceuticals (Netherland) and others.
Segmentation Overview
AMA Research has segmented the market of Global Nasopharyngeal Cancer market by Type (Keratinizing Squamous Cell Carcinoma, Nonkeratinizing Squamous Cell Carcinoma and Undifferentiated or Poorly Differentiated), Application (Hospitals, Clinics and Cancer Treatment and Rehabilitation Centers) and Region.
On the basis of geography, the market of Nasopharyngeal Cancer has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Surgery will boost the Nasopharyngeal Cancer market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Surging Clinical Trials for New Nasopharyngeal Cancer Drug
Market Growth Drivers:
Rising Burden of the Cancer Disease and Growing Awareness Towards Diagnosis and Treatment
Challenges:
Side Effects Associated with the Disease
Restraints:
High Cost of the Treatment
Opportunities:
Increasing Healthcare Awareness and Rising Spending on Healthcare Technologies in Developing Regions
Market Leaders and their expansionary development strategies
In August 2019, Pfizer Inc. announced the closing of its joint venture with GlaxoSmithKline plc to combine the parties’ respective consumer healthcare businesses to create the world’s largest over-the-counter (OTC) business with robust iconic brands.
In May 2020, A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first known agent to successfully target the virus and disturb its latency in tumor cells in this way.
Key Target Audience
Nasopharyngeal Cancer Drug Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.